SwePub
Sök i LIBRIS databas

  Utökad sökning

hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi)
 

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) > (2000-2004) > (2001) > Hemminki K > VHL gene alteration...

VHL gene alterations in renal cell carcinoma patients : novel hotspot or founder mutations and linkage disequilibrium

Ma, X. (författare)
Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden
Yang, K. (författare)
Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden
Lindblad, Per, 1953- (författare)
Department of Medical Epidemiology, Karolinska Institute, Stockholm, Sweden; Department of Urology, Sundsvall Hospital, Sundsvall, Sweden
visa fler...
Egevad, L. (författare)
Karolinska Institutet
Hemminki, K. (författare)
Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden
visa färre...
 (creator_code:org_t)
2001-09-06
2001
Engelska.
Ingår i: Oncogene. - Hampshire, United Kingdom : Nature Publishing Group. - 0950-9232 .- 1476-5594. ; 20:38, s. 5393-5400
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Mutations in the von Hippel-Lindau (VHL) gene are frequently detected in human sporadic renal cell carcinoma (RCC). We analysed 102 Swedish RCCs for VHL mutations by PCR-SSCP and sequencing. In 47 patients (46.1%), 70 different mutations were found, and most of them represented novel variations of the VHL gene. Mutations in the VHL gene were found in 54% of clear cell renal cell carcinomas (CCRCC) and in 18% of chromophilic cancers but in no chromophobe cancers or oncocytomas (P=0.016). Three novel hotspot or founder mutations were detected in our study: four CCRCCs carried a missense mutation (glutamic acid to lysine) at codon 160 which is critical in the stabilization of the H1 helix of the alpha domain and the alpha-beta domain interface in the VHL protein. Five CCRCCs and one chromophilic RCC harbored a 15-nucleotide in-frame deletion (codons 41-45) at a duplex tandem repeat sequence site. Moreover, this deletion was in linkage disequilibrium with a C-->T transition in the promoter region. The frequency of linkage was 17 times more common than chance. Five patients with this linked mutation resided in the same hospital district and at least three of them showed the two sequence variants in the tumor-adjacent tissue. In 5/6 patients the wild-type allele was lost in the tumor samples, suggesting a causal role for the mutations in RCC. These linked mutations might be novel polymorphisms maintained in a relative isolated population. Multiple mutations in VHL were found in 17 tumors out of 47 tumors with the VHL mutation. A higher multiple mutation detected rate (33%) was observed in grade 3 CCRCCs than those in grade 1 (22%) and grade 2 (9%) (P=0.04). This is evidence on the association between VHL mutation and extent of nuclear atypia.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Age of Onset
Aged
Carcinoma
Renal Cell/*genetics
Cell Nucleus/metabolism
CpG Islands
Exons
Frameshift Mutation
Gene Deletion
Humans
Introns
Kidney Neoplasms/*genetics
*Ligases
*Linkage Disequilibrium
Middle Aged
*Mutation
Mutation
Missense
Polymorphism
Genetic
Polymorphism
Single-Stranded Conformational
Protein Structure
Tertiary
Proteins/*genetics
Sweden
*Tumor Suppressor Proteins
*Ubiquitin-Protein Ligases
Von Hippel-Lindau Tumor Suppressor Protein

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

  • Oncogene (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Ma, X.
Yang, K.
Lindblad, Per, 1 ...
Egevad, L.
Hemminki, K.
Om ämnet
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Klinisk medicin
och Cancer och onkol ...
Artiklar i publikationen
Oncogene
Av lärosätet
Örebro universitet
Karolinska Institutet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy